Market by Product Type, Industry Verticals, and Region | Forecast 2021-2028
The detailed analysis of the global sleep apnea therapeutics and diagnostics market shows that, in terms of revenue, the industry is estimated to grow at a CAGR of 6.90% during the forecasting years 2021-2028. In 2020, the market acquired revenue worth $4356.9 million, and is predicted to reap $8243.2 million by 2028.
Report scope can be customized per your requirements. Request For Customization
According to the
American Sleep Apnea Association (ASAA), sleep apnea is defined as “an
involuntary cessation of breathing that occurs while the patient is asleep.”
Sleep apnea can be further classified into three types, namely obstructive
sleep apnea (OSA), central sleep apnea, and mixed or complex sleep apnea.
Although this condition
can impact any age group, the National Sleep Foundation statistics depicted
that it occurs most regularly in people aged between 55 and 60 years old.
Obstructive sleep apnea (OSA) affects only 2% of children around 6% of adults.
It is more common in men than in women, with twice as many men reporting the
problem. Besides, undiagnosed sleep apnea can cause various chronic conditions,
such as cardiovascular diseases, metabolic disorders, cognitive impairment, and
depression. Furthermore, sleep apnea can further increase the risk of motor
accidents and mortality rates, thereby driving the sleep apnea therapeutics and
diagnostics market growth.
The study aims to get an overview of the sleep
apnea therapeutics and diagnostics market in terms of various factors. Within
this report, the key insights and the market summary regarding the sleep apnea
therapeutics and diagnostics industry have been discussed. Also, the impact of
COVID-19 on the sleep apnea therapeutics and diagnostics market; Porter’s five
forces model; legal, policy & regulatory framework; supply chain outlook;
market attractiveness index; vendor scorecard; and key market strategies have
been studied in detail.
Drivers like the awareness
related to the negative impact of untreated sleep apnea, and the rise in geriatric population and obesity cases, as well
as disturbed sleep due to increased use of gadgets at night-time, are driving
the studied market growth. However, the industry is facing challenges, like the
high cost of sleep apnea devices, unfavorable reimbursement landscape, and lack
of patient adherence to the treatment being recommended, which are obstructing its
growth.
Key opportunities like the increasing usage of at-home monitoring devices and advancements in technology can be leveraged by the industry to reach the projected growth.
Geographies
covered in the sleep apnea therapeutics and diagnostics market by region are:
• North America: Canada and the United
States
• Europe: Russia, Spain, the United
Kingdom, Germany, France, Italy, and Rest of Europe
• Asia-Pacific: New Zealand &
Australia, Japan, India, ASEAN countries, South Korea, China, and Rest of
Asia-Pacific
• Latin America: Mexico, Brazil, and Rest
of Latin America
• Middle East & Africa: The United
Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of the Middle East
& Africa
The
global sleep apnea therapeutics and diagnostics market has been segmented as
follows:
• By Product Type
o Therapeutics
• Positive Airway Pressure (PAP)
Devices
o Continuous Positive Airway Pressure
Devices (CPAP)
o Bilevel Positive Airway Pressure
(BPAP) Devices
• Oxygen Devices
o Oxygen Concentrators
o Portable Oxygen Concentrators
o Liquid Portable Oxygen
• Masks and Accessories
• Oral Appliances
o Mandibular Advancement Devices
o Tongue Retainers
• Adaptive Servo-Ventilation (ASV)
Devices
o Diagnostics and Monitoring
• Polysomnography Device (PSG)
o Clinical PSG Device
o Ambulatory PSG Device
• Oximeter
o Tabletop Oximeter
o Fingertip Oximeter
o Handheld Oximeter
o Wrist-Worn Oximeter
• Actigraphy Monitoring Device
• Respiratory Polygraph
• Sleep Apnea Screening Device
• Other Diagnostics and Monitoring
Devices
• By Industry Verticals
o Hospitals & Sleep Laboratories
o Home Care Settings
The key players engaged
in the sleep apnea therapeutics and diagnostics market are GE Healthcare
(General Electric Company), Cadwell Industries Inc, Resmed Inc, Koninklijke
Philips NV, Fisher & Paykel Healthcare Corporation Limited, Devilbiss
Healthcare LLC, Signifier Medical Technologies Limited, Braebon Medical
Corporation, Smiths Medical Inc, Invacare Corporation, BMC Medical Co Ltd,
Somnomedics GmbH, Nihon Kohden Corporation, Itamar Medical Ltd, Teleflex
Incorporated, Vyaire Medical Inc, and Medtronic PLC.
The strategic analysis
for each of these companies has been covered in detail. The sleep apnea
therapeutics and diagnostics market by company profile helps dive into the data
about the key players in this industry.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER'S
FIVE FORCES MODEL
2.3.1. BARGAINING
POWER OF BUYERS
2.3.2. BARGAINING
POWER OF SUPPLIERS
2.3.3. THREAT
OF SUBSTITUTE PRODUCTS
2.3.4. THREAT
OF NEW ENTRANTS
2.3.5. COMPETITIVE
RIVALRY
2.4. LEGAL,
POLICY & REGULATORY FRAMEWORK
2.5. SUPPLY
CHAIN OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. ACQUISITIONS
& MERGERS
2.8.2. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.8.3. CONTRACTS
AND PARTNERSHIPS
2.8.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
2.9. MARKET
DRIVERS
2.9.1. AWARENESS
RELATED TO THE NEGATIVE IMPACT OF UNTREATED SLEEP APNEA
2.9.2. RISE
IN GERIATRIC POPULATION AND OBESITY CASES
2.9.3. DISTURBED
SLEEP DUE TO INCREASED USE OF GADGETS AT NIGHT-TIME
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SLEEP APNEA DEVICES
2.10.2. UNFAVORABLE
REIMBURSEMENT LANDSCAPE
2.10.3. LACK
OF PATIENT ADHERENCE TO THE TREATMENT RECOMMENDED
2.11. MARKET
OPPORTUNITIES
2.11.1. INCREASING
USAGE OF AT-HOME MONITORING DEVICES
2.11.2. ADVANCEMENTS
IN TECHNOLOGY
3. GLOBAL
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – PRODUCT TYPE
3.1. THERAPEUTICS
3.1.1. POSITIVE
AIRWAY PRESSURE (PAP) DEVICES
3.1.1.1. CONTINUOUS
POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
3.1.1.2. BILEVEL
POSITIVE AIRWAY PRESSURE (BPAP) DEVICES
3.1.2. OXYGEN
DEVICES
3.1.2.1. OXYGEN
CONCENTRATORS
3.1.2.2. PORTABLE
OXYGEN CONCENTRATORS
3.1.2.3. LIQUID
PORTABLE OXYGEN
3.1.3. MASKS
AND ACCESSORIES
3.1.4. ORAL
APPLIANCES
3.1.4.1. MANDIBULAR
ADVANCEMENT DEVICES
3.1.4.2. TONGUE
RETAINERS
3.1.5. ADAPTIVE
SERVO VENTILATION (ASV) DEVICES
3.2. DIAGNOSTICS
AND MONITORING
3.2.1. POLYSOMNOGRAPHY
DEVICE (PSG)
3.2.1.1. CLINICAL
PSG DEVICE
3.2.1.2. AMBULATORY
PSG DEVICE
3.2.2. OXIMETER
3.2.2.1. TABLETOP
OXIMETER
3.2.2.2. FINGERTIP
OXIMETER
3.2.2.3. HANDHELD
OXIMETER
3.2.2.4. WRIST-WORN
OXIMETER
3.2.3. ACTIGRAPHY
MONITORING DEVICE
3.2.4. RESPIRATORY
POLYGRAPH
3.2.5. SLEEP
APNEA SCREENING DEVICE
3.2.6. OTHER
DIAGNOSTICS AND MONITORING DEVICES
4. GLOBAL
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – INDUSTRY VERTICALS
4.1. HOSPITALS
& SLEEP LABORATORIES
4.2. HOME
CARE SETTINGS
5. GLOBAL
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1. MARKET
BY PRODUCT TYPE
5.1.1.1. THERAPEUTICS
MARKET BY TYPE
5.1.1.2. DIAGNOSTICS
AND MONITORING MARKET BY TYPE
5.1.2. MARKET
BY INDUSTRY VERTICALS
5.1.3. COUNTRY
ANALYSIS
5.1.3.1. THE
UNITED STATES
5.1.3.2. CANADA
5.2. EUROPE
5.2.1. MARKET
BY PRODUCT TYPE
5.2.1.1. THERAPEUTICS
MARKET BY TYPE
5.2.1.2. DIAGNOSTICS
AND MONITORING MARKET BY TYPE
5.2.2. MARKET
BY INDUSTRY VERTICALS
5.2.3. COUNTRY
ANALYSIS
5.2.3.1. GERMANY
5.2.3.2. FRANCE
5.2.3.3. UNITED
KINGDOM
5.2.3.4. ITALY
5.2.3.5. RUSSIA
5.2.3.6. SPAIN
5.2.3.7. REST
OF EUROPE
5.3. ASIA-PACIFIC
5.3.1. MARKET
SIZE & ESTIMATES
5.3.2. MARKET
BY PRODUCT TYPE
5.3.2.1. THERAPEUTICS
MARKET BY TYPE
5.3.2.2. DIAGNOSTICS
AND MONITORING MARKET BY TYPE
5.3.3. MARKET
BY INDUSTRY VERTICALS
5.3.4. COUNTRY
ANALYSIS
5.3.4.1. CHINA
5.3.4.2. JAPAN
5.3.4.3. AUSTRALIA
& NEW ZEALAND
5.3.4.4. INDIA
5.3.4.5. SOUTH
KOREA
5.3.4.6. ASEAN
COUNTRIES
5.3.4.7. REST
OF ASIA-PACIFIC
5.4. LATIN
AMERICA
5.4.1. MARKET
BY PRODUCT TYPE
5.4.1.1. THERAPEUTICS
MARKET BY TYPE
5.4.1.2. DIAGNOSTICS
AND MONITORING MARKET BY TYPE
5.4.2. MARKET
BY INDUSTRY VERTICALS
5.4.3. COUNTRY
ANALYSIS
5.4.3.1. BRAZIL
5.4.3.2. MEXICO
5.4.3.3. REST
OF LATIN AMERICA
5.5. MIDDLE
EAST AND AFRICA
5.5.1. MARKET
BY PRODUCT TYPE
5.5.1.1. THERAPEUTICS
MARKET BY TYPE
5.5.1.2. DIAGNOSTICS
AND MONITORING MARKET BY TYPE
5.5.2. MARKET
BY INDUSTRY VERTICALS
5.5.3. COUNTRY
ANALYSIS
5.5.3.1. SAUDI
ARABIA
5.5.3.2. UNITED
ARAB EMIRATES
5.5.3.3. TURKEY
5.5.3.4. SOUTH
AFRICA
5.5.3.5. REST
OF MIDDLE EAST & AFRICA
6. COMPETITIVE
LANDSCAPE
6.1. BMC
MEDICAL CO LTD
6.2. BRAEBON
MEDICAL CORPORATION
6.3. CADWELL
INDUSTRIES INC
6.4. DEVILBISS
HEALTHCARE LLC
6.5. FISHER
& PAYKEL HEALTHCARE CORPORATION LIMITED
6.6. GE
HEALTHCARE (GENERAL ELECTRIC COMPANY)
6.7. INVACARE
CORPORATION
6.8. ITAMAR
MEDICAL LTD
6.9. KONINKLIJKE
PHILIPS NV
6.10. MEDTRONIC
PLC
6.11. NIHON
KOHDEN CORPORATION
6.12. SIGNIFIER
MEDICAL TECHNOLOGIES LIMITED
6.13. RESMED
INC
6.14. SMITHS
MEDICAL INC
6.15. SOMNOMEDICS
GMBH
6.16. TELEFLEX
INCORPORATED
6.17. VYAIRE
MEDICAL INC
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: ACQUISITIONS
& MERGERS
TABLE 4: NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 5: CONTRACTS AND
PARTNERSHIPS
TABLE 6: BUSINESS
EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
TABLE 7: POPULATION
AGED 65 YEARS OR OVER BY REGION, 2019 AND 2050 (IN MILLION)
TABLE 8: GLOBAL SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN $
MILLION)
TABLE 9: GLOBAL
THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL
POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET, BY TYPE, 2021-2028 (IN $
MILLION)
TABLE 11: GLOBAL OXYGEN
DEVICES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL ORAL
APPLIANCES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL
DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL
POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: GLOBAL
OXIMETER MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN
$ MILLION)
TABLE 17: GLOBAL SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (IN $
MILLION)
TABLE 19: NORTH AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN
$ MILLION)
TABLE 20: NORTH AMERICA
THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA
DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS,
2021-2028 (IN $ MILLION)
TABLE 23: EUROPE SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 24: EUROPE SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN $
MILLION)
TABLE 25: EUROPE
THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 26: EUROPE
DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 27: EUROPE SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN
$ MILLION)
TABLE 28: ASIA-PACIFIC
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (IN $
MILLION)
TABLE 29: ASIA-PACIFIC
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN
$ MILLION)
TABLE 30: ASIA-PACIFIC
THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC
DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS,
2021-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2021-2028 (IN $
MILLION)
TABLE 34: LATIN AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN
$ MILLION)
TABLE 35: LATIN AMERICA
THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 36: LATIN AMERICA
DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS,
2021-2028 (IN $ MILLION)
TABLE 38: MIDDLE EAST
AND AFRICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY,
2021-2028 (IN $ MILLION)
TABLE 39: MIDDLE EAST AND
AFRICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE,
2021-2028 (IN $ MILLION)
TABLE 40: MIDDLE EAST
AND AFRICA THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 41: MIDDLE EAST
AND AFRICA DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 42: MIDDLE EAST
AND AFRICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY
VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 1: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)
FIGURE 2: PORTER'S FIVE FORCES MODEL
FIGURE 3: ADVANTAGES OF PORTABLE CONTINUOUS POSITIVE AIRWAY PRESSURE
DEVICES
FIGURE 4: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
PRODUCT TYPE, 2020 & 2028 (IN %)
FIGURE 5: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE AIRWAY
PRESSURE (PAP) DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL SLEEP APNEA POSITIVE AIRWAY PRESSURE (PAP) DEVICES
MARKET, BY CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES, 2021-2028 (IN $
MILLION)
FIGURE 8: GLOBAL SLEEP APNEA POSITIVE AIRWAY PRESSURE (PAP) DEVICES
MARKET, BY BILEVEL POSITIVE AIRWAY PRESSURE (BPAP) DEVICES, 2021-2028 (IN $
MILLION)
FIGURE 9: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN DEVICES,
2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL SLEEP APNEA OXYGEN DEVICES MARKET, BY OXYGEN
CONCENTRATORS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL SLEEP APNEA OXYGEN DEVICES MARKET, BY PORTABLE OXYGEN
CONCENTRATORS, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL SLEEP APNEA OXYGEN DEVICES MARKET, BY LIQUID PORTABLE
OXYGEN, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND
ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY ORAL APPLIANCES,
2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL SLEEP APNEA ORAL APPLIANCES MARKET, BY MANDIBULAR
ADVANCEMENT DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL SLEEP APNEA ORAL APPLIANCES MARKET, BY TONGUE
RETAINERS, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE SERVO
VENTILATION (ASV) DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
DIAGNOSTICS AND MONITORING, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY POLYSOMNOGRAPHY
DEVICE (PSG), 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY CLINICAL PSG
DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY AMBULATORY PSG
DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER,
2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL OXIMETER MARKET, BY TABLETOP OXIMETER, 2021-2028 (IN $
MILLION)
FIGURE 24: GLOBAL OXIMETER MARKET, BY FINGERTIP OXIMETER, 2021-2028 (IN $
MILLION)
FIGURE 25: GLOBAL OXIMETER MARKET, BY HANDHELD OXIMETER, 2021-2028 (IN $
MILLION)
FIGURE 26: GLOBAL OXIMETER MARKET, BY WRIST-WORN OXIMETER, 2021-2028 (IN
$ MILLION)
FIGURE 27: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY
MONITORING DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 28: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY RESPIRATORY
POLYGRAPH, 2021-2028 (IN $ MILLION)
FIGURE 29: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY SLEEP APNEA
SCREENING DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 30: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY OTHER DIAGNOSTICS
AND MONITORING DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 31: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 32: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
HOSPITALS & SLEEP LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 33: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
HOME CARE SETTINGS, 2021-2028 (IN $ MILLION)
FIGURE 34: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
REGION, 2020 & 2028 (IN %)
FIGURE 35: THE UNITED STATES SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: CANADA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 37: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 38: FRANCE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 39: UNITED KINGDOM SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 40: ITALY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 41: RUSSIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 42: SPAIN SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 43: REST OF EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 44: CHINA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 45: JAPAN SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 46: AUSTRALIA & NEW ZEALAND SLEEP APNEA THERAPEUTICS AND
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: INDIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 48: SOUTH KOREA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 49: ASEAN COUNTRIES SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 50: REST OF ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 51: BRAZIL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 52: MEXICO SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 53: REST OF LATIN AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 54: SAUDI ARABIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 55: UNITED ARAB EMIRATES SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 56: TURKEY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 57: SOUTH AFRICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 58: REST OF MIDDLE EAST & AFRICA SLEEP APNEA THERAPEUTICS AND
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)